Filing Details

Accession Number:
0000899243-19-024190
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-24 18:23:32
Reporting Period:
2019-09-23
Accepted Time:
2019-09-24 18:23:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK Pharmaceutical Preparations (2834) 455500552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1696493 June Lee C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
Evp, Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-23 12,625 $11.95 17,204 No 4 M Direct
Common Stock Disposition 2019-09-23 3,929 $58.33 13,275 No 4 S Direct
Common Stock Disposition 2019-09-23 4,161 $58.97 9,114 No 4 S Direct
Common Stock Disposition 2019-09-23 800 $59.95 8,314 No 4 S Direct
Common Stock Disposition 2019-09-23 4,161 $61.09 4,153 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-09-23 12,625 $0.00 12,625 $11.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
115,617 2027-01-31 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
  2. Represents the weighted average sale price of the shares sold ranging from $57.69 to $58.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
  3. Represents the weighted average sale price of the shares sold ranging from $58.69 to $59.65 per share.
  4. Represents the weighted average sale price of the shares sold ranging from $59.69 to $60.64 per share.
  5. Represents the weighted average sale price of the shares sold ranging from $60.69 to $61.65 per share.
  6. 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.